Advertisement: S-Tech mid banner 3
Advertisement: partnersand mid banner
Advertisement: EBCam mid banner
Advertisement: Simpsons Creative
Advertisement: RSM mid banner
Mid banner advertisement: BDO
ARM Innovation Hub
Advertisement: HCR Hewitsons mid banner
Advertisement: Wild Knight Vodka
Advertisement: Kao Data Centre mid banner
Advertisement: Cambridge Network mid banner
Barr Ellison Solicitors – commercial property
Advertisement: Excalibur Healthcare mid banner
Advertisement: CJBS mid banner
Advertisement: Mogrify mid banner
Advertisement: TTP
5 September, 2021 - 22:21 By Tony Quested

AstraZeneca alliance in Kenya aims to bring life-changing treatment to all

AstraZeneca is playing a lead role in chronic disease management in Africa after joining forces with the Pharmaceutical Society of Kenya (PSK) to launch the Kamba Ya Shanga initiative – a pharmacy-led end-to-end digitally integrated patient solution.

The alliance forms part of a shared vision and commitment to work towards a future where all people have access to sustainable healthcare solutions for life-changing treatment.

The COVID-19 pandemic and the growing burden of non-communicable diseases (NCDs) have compelled stakeholders to explore new ways of improving health systems. This, in turn, has stimulated the advancement of healthcare ecosystems that focus on securing continuum of care and improving treatment outcomes whilst also enhancing the patient experience.

The Kamba Ya Shanga initiative is designed to connect all key healthcare players along a patient’s disease management journey. Through the programme patients will be uniquely identified by a pharmacist, have their chronic disease treatment and medication monitored, receive support that ensures optimal treatment and correct use of devices; and be seamlessly referred by the pharmacist to their GP should further consultation be required.

Dr Daniella Munene, CEO of PSK said: “Pharmacists are uniquely positioned to expand reach of healthcare services by participating more in the management of chronic diseases.

“From detection of poorly managed or undiagnosed disease to providing medication therapy management and counselling, pharmacists can have a positive impact on therapeutic outcomes in patients on long-term medication for both communicable and non-communicable diseases.”

Barbara Nel, AstraZeneca Country President for African Cluster, added: “At AstraZeneca we believe that patient experiences and outcomes are our shared responsibility and that innovation doesn’t happen in isolation.

“Our pharmacists play a critical role in the continuance of care for patients, especially in the current landscape. We are delighted to be partnering with PSK in the launch of Kamba Ya Shanga, which is a Swahili term that essentially means ‘a beautiful string of beads’. 

“The string of beads represents the link between the patient, the pharmacist, and the doctor, transforming the ecosystem for patients whilst enabling pharmacies to direct them to a relevant healthcare professional and track their progress and response to medication.”

“By joining forces with PSK we look forward to making an even greater positive impact for patients and healthcare practitioners, achieving results that go beyond what any individual stakeholder can achieve. This is the value of partnerships, with the patient at the centre.”

Headquartered at Cambridge Biomedical Campus, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Newsletter Subscription

Stay informed of the latest news and features